Citation Impact
Citing Papers
Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis
2014 StandoutNobel
Circulating microRNAs as stable blood-based markers for cancer detection
2008 Standout
Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
2011
Hallmarks of Cancer: The Next Generation
2011 Standout
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Inflammation and cancer
2002 StandoutNature
Malignant mesothelioma growth inhibition by agents that target the VEGF and VEGF‐C autocrine loops
2003
Cyclin D1 expression is predictive of occult metastases in head and neck cancer patients with clinically negative cervical lymph nodes
2000
Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy
2004
Deep Sequencing of RNA from Three Different Extracellular Vesicle (EV) Subtypes Released from the Human LIM1863 Colon Cancer Cell Line Uncovers Distinct Mirna-Enrichment Signatures
2014
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
Genetic Ablation of the Aryl Hydrocarbon Receptor Causes Cigarette Smoke-induced Mitochondrial Dysfunction and Apoptosis
2011
Imaging-guided delivery of RNAi for anticancer treatment
2016
Head and neck cancer
2008 Standout
TOR, a Central Controller of Cell Growth
2000 Standout
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Pancreatic cancer
2016 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
TRIBE: Hijacking an RNA-Editing Enzyme to Identify Cell-Specific Targets of RNA-Binding Proteins
2016 StandoutNobel
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.
1998
Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells
2008
The biology of VEGF and its receptors
2003 Standout
Liver Metastases Arising from Well-Differentiated Pancreatic Endocrine Neoplasms Demonstrate Increased VEGF-C Expression
2003
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Pancreatic Adenocarcinoma
2014 Standout
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
2007 StandoutNature
Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer
2013
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Cyclin D as a therapeutic target in cancer
2011
Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression
2012 StandoutNobel
Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples
2007
Taking dendritic cells into medicine
2007 StandoutNatureNobel
VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic β cell carcinogenesis
2002
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
2003 Standout
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
2010
Macrophage plasticity and polarization: in vivo veritas
2012 Standout
Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b–ZEB1 axis
2012
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Pancreatic Cancer
2010 Standout
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
Role of Transforming Growth Factor-beta Signaling in Cancer
2000
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
2000
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Palbociclib and Letrozole in Advanced Breast Cancer
2016 Standout
Multicomponent Analysis of the Pancreatic Adenocarcinoma Progression Model Using a Pancreatic Intraepithelial Neoplasia Tissue Microarray
2003
Immunotherapy for pancreatic cancer — science driving clinical progress
2005
Cancer-related inflammation
2008 StandoutNature
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Vascular endothelial growth factor receptor‐1 promotes migration and invasion in pancreatic carcinoma cell lines
2005
Angiogenesis as a therapeutic target
2005 StandoutNature
Genetics and biology of pancreatic ductal adenocarcinoma
2006
Advances in Malignant Mesothelioma
2005 Standout
Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second‐line therapy for patients with advanced pancreatic cancer
2008
MEMO1, a new IRS1-interacting protein, induces epithelial–mesenchymal transition in mammary epithelial cells
2012
Pancreatic cancer
2011 Standout
Caenorhabditis elegans ALG-1 antimorphic mutations uncover functions for Argonaute in microRNA guide strand selection and passenger strand disposal
2015 StandoutNobel
Detection and localization of MIP‐3α/LARC/exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer
1999
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Photoexpulsion of Surface-Grafted Ruthenium Complexes and Subsequent Release of Cytotoxic Cargos to Cancer Cells from Mesoporous Silica Nanoparticles
2013 StandoutNobel
Genetic Variation as a Guide to Drug Development
1998 Science
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
2011 Standout
Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel.
2007
Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts
2004
Alternative activation of tumor-associated macrophages by IL-4
2010
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
The Pancreas Cancer Microenvironment
2012
Magnetic drug targeting: biodistribution and dependency on magnetic field strength
2002
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Randomized phase II /III clinical trial of elpamotide for patients with advanced pancreatic cancer: PEGASUS ‐PC Study
2015
Limits to Thymidylate Synthase andTP53Genes as Predictive Determinants for Fluoropyrimidine Sensitivity and Further Evidence for RNA-Based Toxicity as a Major Influence
2009
Luminescent Functional Metal–Organic Frameworks
2011 Standout
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
Involvement of TRAIL and its receptors in viral hepatitis
2002
Post-Transcriptional Controls by Ribonucleoprotein Complexes in the Acquisition of Drug Resistance
2013
Identification of fibroblast growth factor-5 as an overexpressed antigen in multiple human adenocarcinomas.
2001
Signal Transduction by the TGF-β Superfamily
2002 StandoutScience
Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases
2007
Irinotecan Plus Oxaliplatin and Leucovorin-Modulated Fluorouracil in Advanced Pancreatic Cancer—A Groupe Tumeurs Digestives of the Fédération Nationale des Centres de Lutte Contre le Cancer Study
2005
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
2018 StandoutNobel
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
Locoregional cancer treatment with magnetic drug targeting.
2000
Phase II Trial of Bevacizumab Plus Gemcitabine in Patients With Advanced Pancreatic Cancer
2005
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
IL-13 Effector Functions
2003
Regulation of cell growth and cyclin D1 expression by the constitutively active FRAP-p70s6K pathway in human pancreatic cancer cells.
1999
The two faces of transforming growth factor β in carcinogenesis
2003 Standout
Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas
2002
Works of Marko Kornmann being referenced
Enhanced fibroblast growth factor 5 expression in stromal and exocrine elements of the pancreas in chronic pancreatitis
1998
Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells
2010
Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions
2005
Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions
1997
TRAIL and its receptors in the colonic epithelium: A putative role in the defense of viral infections
2002
Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer
2000
Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy
1997
Regional chemotherapy of non-resectable liver metastases from colorectal cancer - literature and institutional review
1999
Coexpression of FAS and FAS-Ligand in Chronic Pancreatitis: Correlation with Apoptosis
2000
Fas and Fas-Ligand Expression in Human Pancreatic Cancer
2000
Actinomycin D induces apoptosis and inhibits growth of pancreatic cancer cells
2000
Interleukin-13 exerts autocrine growth-promoting effects on human pancreatic cancer, and its expression correlates with a propensity for lymph node metastases
2008
Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases
1999
Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum.
1998
IIIc isoform of fibroblast growth factor receptor 1 is overexpressed in human pancreatic cancer and enhances tumorigenicity of hamster ductal cells
2002
TGF-?-1 up-regulates cyclin D1 expression in colo-357 cells, whereas suppression of cyclin d1 levels is associated with down-regulation of the type I TGF-? receptor
1999
Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
2003
Prognostic Values of microRNAs in Colorectal Cancer
2006
Pancreatic cancer cells express interleukin-13 and -4 receptors, and their growth is inhibited by Pseudomonas exotoxin coupled to interleukin-13 and -4.
1999
Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer.
1998
Increased Expression of Insulin Receptor Substrate-1 in Human Pancreatic Cancer
1996
Prognostic Values of microRNAs in Colorectal Cancer.
2006
Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes.
1999
Oxaliplatin exerts potent in vitro cytotoxicity in colorectal and pancreatic cancer cell lines and liver metastases.
2000